×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ARTV – artiva biotherapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ARTV
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/29
06:16 am
artv
Artiva Biotherapeutics (NASDAQ:ARTV) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Medium
Report
Artiva Biotherapeutics (NASDAQ:ARTV) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
1/21
10:32 am
artv
Artiva Biotherapeutics Announces Upcoming Presentations at the 2026 Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® (Tandem Meetings) Highlighting Cost-Effectiveness of AlloNK in a Community Rheumatology Practice and Continued Durability
Low
Report
Artiva Biotherapeutics Announces Upcoming Presentations at the 2026 Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® (Tandem Meetings) Highlighting Cost-Effectiveness of AlloNK in a Community Rheumatology Practice and Continued Durability
1/21
08:00 am
artv
Artiva Biotherapeutics Announces Upcoming Presentations at the 2026 Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® (Tandem Meetings) Highlighting Cost-Effectiveness of AlloNK in a Community Rheumatology Practice and Continued Durability
Medium
Report
Artiva Biotherapeutics Announces Upcoming Presentations at the 2026 Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® (Tandem Meetings) Highlighting Cost-Effectiveness of AlloNK in a Community Rheumatology Practice and Continued Durability
1/15
08:29 pm
artv
Artiva Biotherapeutics: Upcoming Data Presentations May Bring Them Out Of Being Ignored [Seeking Alpha]
Medium
Report
Artiva Biotherapeutics: Upcoming Data Presentations May Bring Them Out Of Being Ignored [Seeking Alpha]
1/8
03:30 am
artv
Seasoned biotherapeutics leader Thomas J. Farrell joins NanoSyrinx as CEO to advance Nanosyringe-enabled intracellular medicines
Low
Report
Seasoned biotherapeutics leader Thomas J. Farrell joins NanoSyrinx as CEO to advance Nanosyringe-enabled intracellular medicines
1/8
03:30 am
artv
Seasoned biotherapeutics leader Thomas J. Farrell joins NanoSyrinx as CEO to advance Nanosyringe-enabled intracellular medicines
Low
Report
Seasoned biotherapeutics leader Thomas J. Farrell joins NanoSyrinx as CEO to advance Nanosyringe-enabled intracellular medicines
12/19
06:30 pm
artv
Artiva Biotherapeutics (ARTV): Evaluating Valuation After CEO's Latest Insider Share Sale [Yahoo! Finance]
Medium
Report
Artiva Biotherapeutics (ARTV): Evaluating Valuation After CEO's Latest Insider Share Sale [Yahoo! Finance]
12/14
06:16 am
artv
Wedbush Predicts Up to ~600% Jump for These 2 ‘Strong Buy' Stocks [Yahoo! Finance]
High
Report
Wedbush Predicts Up to ~600% Jump for These 2 ‘Strong Buy' Stocks [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/15
09:19 pm
artv
Form 4 Artiva Biotherapeutics, For: Dec 15 Filed by: Aslan Fred
High
Report
Form 4 Artiva Biotherapeutics, For: Dec 15 Filed by: Aslan Fred
12/15
04:18 pm
artv
Form 144 Artiva Biotherapeutics, Filed by: Aslan Fred
High
Report
Form 144 Artiva Biotherapeutics, Filed by: Aslan Fred
12/12
07:21 pm
artv
Form 4 Artiva Biotherapeutics, For: Dec 12 Filed by: Horan Christopher
High
Report
Form 4 Artiva Biotherapeutics, For: Dec 12 Filed by: Horan Christopher
12/12
07:21 pm
artv
Form 4 Artiva Biotherapeutics, For: Dec 12 Filed by: Raymon Heather
High
Report
Form 4 Artiva Biotherapeutics, For: Dec 12 Filed by: Raymon Heather
12/12
07:19 pm
artv
Form 4 Artiva Biotherapeutics, For: Dec 12 Filed by: Bush Jennifer
High
Report
Form 4 Artiva Biotherapeutics, For: Dec 12 Filed by: Bush Jennifer
12/12
07:19 pm
artv
Form 4 Artiva Biotherapeutics, For: Dec 12 Filed by: Aslan Fred
High
Report
Form 4 Artiva Biotherapeutics, For: Dec 12 Filed by: Aslan Fred
12/12
05:24 pm
artv
Form 8-K Artiva Biotherapeutics, For: Dec 10
High
Report
Form 8-K Artiva Biotherapeutics, For: Dec 10
11/17
08:39 pm
artv
Form 4 Artiva Biotherapeutics, For: Nov 15 Filed by: Horan Christopher
High
Report
Form 4 Artiva Biotherapeutics, For: Nov 15 Filed by: Horan Christopher
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: